Low-dose multivalent COVID-19 mRNA vaccines enhance broadly cross-reactive antibodies and protective immune responses of co-administered protein-based vaccines. uri icon

authors

  • Liu, Rong
  • Le, Chau Thuy Tien
  • Shin, Chong Hyun
  • Du, Lanying
  • Manish Kumar, MD
  • Kang, Sang-Moo
  • Patterson, Lila
  • Yeasmin, Mahmuda
  • Kim, Ki-Hye
  • Park, Bo Ryoung
  • Bhatnagar, Noopur
  • Raha, Jannatul Ruhan
  • Grovenstein, Phillip
  • Pal, Surya Sekhar

publication date

  • March 21, 2026